Some modern methods of diagnosis and pathogenetic therapy of multiple sclerosis
- Authors: Stolyarov I.D.1,2,3, Bisaga G.N.1,2,3, Votintseva M.V.1,2,3, Ilves A.G.1,2,3, Nikiforova I.G.1,2,3, Nikolaeva N.V.1,2,3, Rudas M.S.1,2,3, Petrov A.M.1,2,3, Prakhova L.N.1,2,3, Totolyan N.A.1,2,3, Skoromets A.A.1,2,3
-
Affiliations:
- Institute of the Human Brain RAS
- State Medical University named after acad. I.P. Pavlova
- Military-medical Academy
- Issue: Vol XXXIV, No 1-2 (2002)
- Pages: 65-72
- Section: Reviews
- URL: https://journals.rcsi.science/1027-4898/article/view/87566
- DOI: https://doi.org/10.17816/nb87566
- ID: 87566
Cite item
Full Text
Abstract
Multiple sclerosis (MS) is a severe chronic disease of the central nervous system (CNS) that affects young people and quickly leads to disability. Until now, the pathogenesis of this neurological disease, which is the most expensive for society, has not been fully elucidated, and the drugs used to treat MS patients can only slightly suspend but not interrupt the development of the disease. At the same time, the possibilities of diagnosing and treating MS have expanded due to the active study and implementation of neuroimaging, neuroimmunological and neurophysiological methods, and the use of new immunocorrecting genetically engineered drugs.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
I. D. Stolyarov
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
G. N. Bisaga
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
M. V. Votintseva
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
A. G. Ilves
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
I. G. Nikiforova
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
N. V. Nikolaeva
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
M. S. Rudas
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
A. M. Petrov
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
L. N. Prakhova
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
N. A. Totolyan
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
A. A. Skoromets
Institute of the Human Brain RAS; State Medical University named after acad. I.P. Pavlova; Military-medical Academy
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg; St. Petersburg
References
- Абрамов В.В.// Иммунология. — 1996. — №1. — С. 60—61.
- Бисага Г.Н., Поздняков А.В. В кн.: Рассеянный склероз. Избранные вопросы теории и практики. — М., 2000. — С. 222—283.
- Гусев Е.И., Демина Т.Л., Бойко А.Н., Татаринова М.Ю. // Журн. неврол. и психиатр. —1992. — № 2. — С. 14—18.
- Гусев Е.И., Демина Т.Л., Бойко А.Н. Рассеянный склероз. — Москва, 1997.
- Гусев Е.И., Бойко А.Н. // Журн. неврол. и психиатр. — 2000. — № 11.—С. 54—59.
- Демина Т.Л., Бойко А.Н., Пинегин Б.В., Гусев Е.И. В сб.: Диагностика и лечение демиелинизирующих заболеваний нервной системы. —Ярославль, 1998. — С. 26—35.
- Завалишин И.А. В кн.: Хохлов А.П., Савченко Ю.Н. Миелопатии и демиелинизирующие заболевания. — М, 1990.— С.93—102.
- Завалишин И.А., Яхно Н.Н., Жученко Т.Д., Ниязбекова А.С. // Журн. неврол. и психиатр. —1997. —№12.
- Оганезов В.К., Бойко А.Н., Иванов А.Е. и др. // В сб.: Клиническая нейроиммунология на пороге 21 века. — СПб., 1992. — С. 56—60.
- Столяров И.Д., Огурцов Р.П. и др. //Нейроиммунология. Нейроимидж. / Тез. докл. конф. 25—27 мая 1995 г. в Санкт-Петербурге. — СПб, 1995. — С. 116—118.
- Столяров И.Д., Петров А.М., Николаева Н.В., Ильвес А.Г. Основы иммунокоррекции. Иммунотропные препараты. — СПб, 1999.
- Столяров И.Д., Петров А.М., Огурцов Р.П., Рудас М.С., Вотинцева М.В., Ивашкова Е.В. и др. // Физиол. человека. — 1999.— Т.25. — № 5. — С. 49—52.
- Тотолян Н.А., Грязева И.В., Климович В.Б., Тотолян А.А.// Иммунология. — 1994. — №1. —С. 54—58.
- Тотолян Н.А., Лугакова О.В.// Журн. неврол. и психиатр. — 1996. —№4. — С. 75—77.
- Тотолян Н.А., Скоромец А.А., Барбас И.М., Трофимова Т.Н., Тотолян А.А. // Ученые записки. — 2000. — Т. VII. — №3. — С. 37—48.
- Amason В. et al.// International MS Journal. — 1997. — Vol. 4. — №. 2. — P. 40—42.
- Bakshi R., Miletich R.S., Kinkel P.R. et al.// Journal of Neuroimaging. — 1998. — № 8. — P. 4.
- Balashov K.E., Khoury S.J., Hafler D.A., Weiner H.L. / J. Clin. Invest. — 1995. — Vol. 95 —P.232—241.
- Barkhof F. et al.// Multiple Sclerosis. — 1998. — Vol. 4. — № 4. — P.298.
- Bertolotto et al.// MS. — 1999. — Vol. 5. — Suppl. 1. — P. S92.
- Blinkenberg M., Rune K, Jonsson A. et al.// Acta Neurol Scand. — 1996. —№ 94. — P. 310—313.
- Canella B., Raine C.S.// Ann. Neurol. — 1995 — Vol.37 — P.424.
- Craig J.C., Hawins S.A. Swallow M.W. et al.// Clin. Exp. Immunol. — 1985. — Vol.61. — P.548—555.
- European Study Group on Interferon beta 1-b in Secondary Progressive MS. Placebo-controlled multicentre randomised trial of interferon beta lb in treatment of secondary progressive multiple sclerosis.// Lancet. — 1998. — Vol.352. — № 9139. —P.1491—1497.
- Fazekas F. et al.// Neurology. — 1988. — Vol. 38. — № 12. — P. 1822—1825.
- Filippi M., Campi A., Dousser V. et al.// Neurology. — 1995. — Vol.45 — P.478—482.
- Giovannoni G., Thompson E.J., Furrows S. et al.// Multiple Sclerosis. — 2000. — Vol.6. — Suppl. 1. — P. S4.
- Glabinski A., Obryant S., Ransoholf R.M. et al. // Multiple Sclerosis. — 1999. — Vol.5. — Suppl. 1. — P. S29.
- Imamura K., Suzumura A., Hauashi F., Marunouchi T. // Acta Neurol. Scand. — 1993. — Vol. 87. — P.281.
- Johnson K.P. et al.// Multiple Sclerosis. — 2000. — № 6. — P. 255—266.
- Kappos L. et al.// Multiple Sclerosis. — 1995. — Vol. 1. — P. S64—S66.
- Miller D.H., Albert P.S., Barkhof F. et al. // Ann. Neurol.— 1996. — Vof.36. — P. 6—16.
- Navikas V., Matusevicius D., Soderstrom M. et al. // J. Neuroimmunol. — 1996 — Vol.64. — P.63.
- Paty D.W.// European Journal of Neurology. — 1998 — Vol. 5. — Suppl. 2. — P. S15—S16.
- Paty D.W., Oger J.J.F, Kastrikoff L.F. // Neurology. — 1988. — Vol. 38. — № 2. — P. 180—184.
- Petrov A., Nikolaeva N., Ivashkova E., Ilves A., Seliverstova N., Stoliarov I. // Revue Neurologique. Abstracts of 16th Congr. of the European Committee for Treatment and Research in Multiple Sclerosis. Toulouse. France. — 2000. — Vol.156. — Suppl.3. — P.3S175.
- Rieckmann P., Albrecht M., Kitze B. et al. // Neurology. — 1994. — Vol.44. — P.1523—1526.
- Rio et al. // MS. — 1999. — Vol. 5. — Suppl. 1. — P. S92.
- Roelcke U. et al. // Neurology. — 1997. — № 48. — P. 1566—1571.
- Rudkin T.M., Arnold D.L. // Arch. Neurol. — 1999.— Vol. 56. — S919—S926.
- Schmidt S. et al. //Brain. — 1997.— Vol.120. — P. 1437—1445.
- Segal B. et al.// MS. — 1999. — Vol. 5. — Suppl. 1. - P. S66.
- Siva A., Kesselring J., Thompson A. Frontiers in Multiple Sclerosis. — UK: London, 1999.
- Stoliarov I., Petrov A., Ogurtsov R., Votintseva M. et al.//Management Early MS Acros Europe. /Abstr. 4th Annual Meeting of RIMS. —Helsinki, 1998. — P.61.
- Sun X et al.// Ann. Nucl. Med. — 1988. — Vol.12. — № 2. — P. 89—94.
- Tilg H., Trehu E., Atkins M.B. et al.// Blood. —1994. — Vol.83. — P.113—118.
- Valli A. et al. // J. Clin. Invest. — 1993. — Vol. 91.- P.616—628.
- Warren J.S.// Crit. Rev. Clin. Lab. Sci. —1990. — Vol.28. - P. 37—59.
- Weber F. et al.// MS. — 1999. — Vol. 5. — Suppl. 1. - P. S71.
- Wekerle H., Linington Ch. // First Congress of the European Federation of Neurological Sciences. Marsell, 9—14 Sept. 1995 — Teaching Course Neuroimmunology — 1995 — P.1—13.
- Wucherpfenning K.F, Weiner H.L., Hafler D.A.// Cell. - 1995. — Vol.80. — P.695—705.